Cargando…

Moyamoya: An Update and Review

This article is a clinical review of Moyamoya disease (MMD) and Moyamoya syndrome (MMS). We review the incidence, epidemiology, pathology, historical context, clinical and radiographic findings, diagnostic imaging modalities, radiographic grading systems, the effectiveness of medical, interventional...

Descripción completa

Detalles Bibliográficos
Autores principales:	Berry, James A, Cortez, Vladimir, Toor, Harjyot, Saini, Harneel, Siddiqi, Javed
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cureus 2020
Materias:	Neurology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7667711/ https://www.ncbi.nlm.nih.gov/pubmed/33209550 http://dx.doi.org/10.7759/cureus.10994

Ejemplares similares

Moyamoya Disease: A Review of Current Literature
por: Gupta, Apurv, et al.
Publicado: (2020)

Western Moyamoya Phenotype: A Scoping Review
por: Miller, Raphael, et al.
Publicado: (2021)

Methylnaltrexone and Naloxone for Opioid-induced Constipation in the Critical Care Setting
por: Saini, Harneel S, et al.
Publicado: (2020)

Editorial: Moyamoya disease
por: Gu, Yuxiang
Publicado: (2022)

Increased Brain Tissue Oxygen Monitoring Threshold to Improve Hospital Course in Traumatic Brain Injury Patients
por: Patchana, Tye, et al.
Publicado: (2020)

Epidemiology of Moyamoya Angiopathy in Eastern India
por: Das, Shambaditya, et al.
Publicado: (2022)

APOE as potential biomarkers of moyamoya disease
por: Wu, Haibin, et al.
Publicado: (2023)

Indirect revascularization vs. non-surgical treatment for Moyamoya disease and Moyamoya syndrome: A comparative effectiveness study
por: Wang, Yixuan, et al.
Publicado: (2022)

Burden of dilated perivascular spaces in patients with moyamoya disease and moyamoya syndrome is related to middle cerebral artery stenosis
por: Han, Guangsong, et al.
Publicado: (2023)

Beta-Thalassemia Presenting as Moyamoya Syndrome With a Review of Skeletal Manifestations
por: Sunil, Aswathy, et al.
Publicado: (2023)

Non-invasive Urinary Biomarkers in Moyamoya Disease
por: Sesen, Julie, et al.
Publicado: (2021)

Pathophysiology of Vascular Stenosis and Remodeling in Moyamoya Disease
por: Fox, Brandon M., et al.
Publicado: (2021)

Surgical Management of Failed Revascularization in Moyamoya Vasculopathy
por: Lucia, Kristin, et al.
Publicado: (2021)

Application of DTI and fMRI in moyamoya disease
por: Hao, Xiaokuan, et al.
Publicado: (2022)

Potential predictors for progression of moyamoya disease: A systematic review and meta-analysis
por: Cao, Jun, et al.
Publicado: (2023)

Increased Autoimmunity in Individuals With Down Syndrome and Moyamoya Disease
por: Santoro, Jonathan D., et al.
Publicado: (2021)

Moyamoya Disease in a Six Month Caucasian Female
por: Moore, Faith D, et al.
Publicado: (2020)

Characterization of Inpatient Moyamoya in the United States: 1988–2004
por: Lee, Darrin J., et al.
Publicado: (2011)

Corrigendum: Pathophysiology of Vascular Stenosis and Remodeling in Moyamoya Disease
por: Fox, Brandon M., et al.
Publicado: (2021)

The Potential Mechanism Behind Native and Therapeutic Collaterals in Moyamoya
por: Bao, Xiang-Yang, et al.
Publicado: (2022)

Editorial: Moyamoya disease – natural history and therapeutic challenges
por: Svedung Wettervik, Teodor, et al.
Publicado: (2023)

Indirect Bypass With Pericranial Transposition for Moyamoya Syndrome in an Infant
por: Ajala, Rodiyah T, et al.
Publicado: (2023)

Benefits and risks of antiplatelet therapy for moyamoya disease: a systematic review and meta-analysis
por: Liu, Tingting, et al.
Publicado: (2023)

Clinical and Radiological Outcomes After Revascularization of Hemorrhagic Moyamoya Disease
por: Kang, Kaijiang, et al.
Publicado: (2020)

Extracranial and Intracranial Vasculopathy With “Moyamoya Phenomenon” in Association With Alagille Syndrome
por: Delaney, Siobhan, et al.
Publicado: (2019)

Angiographic Outcomes of Direct and Combined Bypass Surgery in Moyamoya Disease
por: Ge, Peicong, et al.
Publicado: (2019)

Moyamoya Disease in a Young Female With Neurofibromatosis Type 1
por: Mehkri, Yusuf, et al.
Publicado: (2021)

Progression in Moyamoya Disease: Clinical Features, Neuroimaging Evaluation, and Treatment
por: Zhang, Xin, et al.
Publicado: (2022)

Parent artery occlusion for ruptured aneurysms in moyamoya vessels or on collaterals
por: Zhou, Zibo, et al.
Publicado: (2023)

Clinical value of the systemic immune-inflammation index in moyamoya disease
por: Liu, Erheng, et al.
Publicado: (2023)

Ring Finger Protein 213 in Moyamoya Disease With Pulmonary Arterial Hypertension: A Mini-Review
por: Luo, Yuting, et al.
Publicado: (2022)

Corticostriatal Hypermetabolism in Moyamoya Disease-Induced Hemichorea: Two Case Reports and a Literature Review
por: Xian, Wen-biao, et al.
Publicado: (2021)

A Review of Lumbar Radiculopathy, Diagnosis, and Treatment
por: Berry, James A, et al.
Publicado: (2019)

Moyamoya Disease Associated With Morning Glory Disc Anomaly and Other Ophthalmic Findings: A Mini-Review
por: Wang, Yue-ye, et al.
Publicado: (2020)

A Patient With Multiple Sclerosis and Coexisting Moyamoya Disease: Why and How
por: Si, Xiaoli, et al.
Publicado: (2020)

Cerebral Hemodynamic Changes After Revascularization in Patients With Hemorrhagic Moyamoya Disease
por: Kang, Kaijiang, et al.
Publicado: (2020)

Efficacy and Safety of Antiplatelet Agents for Adult Patients With Ischemic Moyamoya Disease
por: Ye, Fei, et al.
Publicado: (2021)

MMP-9 as a Biomarker for Predicting Hemorrhagic Strokes in Moyamoya Disease
por: Lu, Junlin, et al.
Publicado: (2021)

Moyamoya Disease in a 13-Month-Old Middle Eastern Boy
por: M. Ali, Nashwa, et al.
Publicado: (2021)

Caveolin-1 Promoted Collateral Vessel Formation in Patients With Moyamoya Disease
por: Zhao, Jinbing, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_9olnnhtfron721vni1eijcchi1